Gilead buys US pharma rival Pharmasset
Monday, November 21, 2011 - 11:01
in Mathematics & Economics
US biotech firm Gilead Sciences announced plans Monday to acquire rival Pharmasset, a group specializing in treatments for AIDS and hepatitis, for $11 billion.